Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Gene polymorphisms of CYP3A5 and MDR-1 in Hans renal transplant recipients in Hunan Province].

Shao M, Ye Q, She X, Liu H, Ye S, Niu Y, Ming Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Aug;38(8):824-9. doi: 10.3969/j.issn.1672-7347.2013.08.011. Chinese.

2.

Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.

Loh PT, Lou HX, Zhao Y, Chin YM, Vathsala A.

Transplant Proc. 2008 Jun;40(5):1690-5. doi: 10.1016/j.transproceed.2008.04.010.

PMID:
18589174
3.

Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.

Shi Y, Li Y, Tang J, Zhang J, Zou Y, Cai B, Wang L.

Gene. 2013 Jan 10;512(2):226-31. doi: 10.1016/j.gene.2012.10.048. Epub 2012 Oct 26.

PMID:
23107770
4.

Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.

Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F.

Exp Clin Transplant. 2006 Jun;4(1):416-9.

5.

Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients.

Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Habuchi T, Suzuki T.

Steroids. 2008 Oct;73(11):1052-9. doi: 10.1016/j.steroids.2008.04.002. Epub 2008 Apr 11.

PMID:
18502461
6.

Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation.

Hu YF, Qiu W, Liu ZQ, Zhu LJ, Liu ZQ, Tu JH, Wang D, Li Z, He J, Zhong GP, Zhou G, Zhou HH.

Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1093-8.

PMID:
17042920
7.

Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.

Rong G, Jing L, Deng-Qing L, Hong-Shan Z, Shai-Hong Z, Xin-Min N.

Transplant Proc. 2010 Nov;42(9):3455-8. doi: 10.1016/j.transproceed.2010.08.063.

PMID:
21094796
8.

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients.

Roy JN, Barama A, Poirier C, Vinet B, Roger M.

Pharmacogenet Genomics. 2006 Sep;16(9):659-65.

PMID:
16906020
9.

Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.

Cho JH, Yoon YD, Park JY, Song EJ, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.

Transplant Proc. 2012 Jan;44(1):109-14. doi: 10.1016/j.transproceed.2011.11.004.

PMID:
22310591
10.

Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors.

de Denus S, Zakrzewski M, Barhdadi A, Leblanc MH, Racine N, Bélanger F, Carrier M, Ducharme A, Dubé MP, Turgeon J, White M.

J Heart Lung Transplant. 2011 Mar;30(3):326-31. doi: 10.1016/j.healun.2010.09.015. Epub 2010 Nov 20.

PMID:
21094057
11.

Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.

Wei-lin W, Jing J, Shu-sen Z, Li-hua W, Ting-bo L, Song-feng Y, Sheng Y.

Liver Transpl. 2006 May;12(5):775-80.

12.

Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors.

Ferraresso M, Turolo S, Ghio L, Tirelli AS, Belingheri M, Villa R, Groppali E, Edefonti A.

Clin Exp Hypertens. 2011;33(6):359-65. doi: 10.3109/10641963.2011.561896. Epub 2011 Aug 18.

PMID:
21851254
13.

Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.

Nair SS, Sarasamma S, Gracious N, George J, Anish TS, Radhakrishnan R.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:197-200.

PMID:
25894154
14.

CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.

Crettol S, Venetz JP, Fontana M, Aubert JD, Pascual M, Eap CB.

Ther Drug Monit. 2008 Dec;30(6):689-99. doi: 10.1097/FTD.0b013e31818a2a60.

PMID:
18978522
15.

Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.

Ogasawara K, Chitnis SD, Gohh RY, Christians U, Akhlaghi F.

Clin Pharmacokinet. 2013 Sep;52(9):751-62. doi: 10.1007/s40262-013-0069-2.

16.

Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation.

Vannaprasaht S, Reungjui S, Supanya D, Sirivongs D, Pongskul C, Avihingsanon Y, Tassaneeyakul W.

Clin Ther. 2013 Nov;35(11):1762-9. doi: 10.1016/j.clinthera.2013.08.019. Epub 2013 Oct 11.

PMID:
24120259
17.

Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre.

Cheng Y, Li H, Meng Y, Liu H, Yang L, Xu T, Yu J, Zhao N, Liu Y.

Int J Clin Pract Suppl. 2015 May;(183):16-22. doi: 10.1111/ijcp.12662.

PMID:
26177012
18.

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.

Santoro A, Felipe CR, Tedesco-Silva H, Medina-Pestana JO, Struchiner CJ, Ojopi EB, Suarez-Kurtz G.

Pharmacogenomics. 2011 Sep;12(9):1293-303. doi: 10.2217/pgs.11.70. Epub 2011 Aug 1.

PMID:
21806386
19.

Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.

Zuo XC, Ng CM, Barrett JS, Luo AJ, Zhang BK, Deng CH, Xi LY, Cheng K, Ming YZ, Yang GP, Pei Q, Zhu LJ, Yuan H, Liao HQ, Ding JJ, Wu D, Zhou YN, Jing NN, Huang ZJ.

Pharmacogenet Genomics. 2013 May;23(5):251-61. doi: 10.1097/FPC.0b013e32835fcbb6.

PMID:
23459029
20.

Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.

Meng XG, Guo CX, Feng GQ, Zhao YC, Zhou BT, Han JL, Chen X, Shi Y, Shi HY, Yin JY, Peng XD, Pei Q, Zhang W, Wang G, He M, Liu M, Yang JK, Zhou HH.

Acta Pharmacol Sin. 2012 Dec;33(12):1563-70. doi: 10.1038/aps.2012.136. Epub 2012 Oct 22.

Supplemental Content

Support Center